Oxford Immunotec Ltd - Product Pipeline Analysis, 2018 Update

Oxford Immunotec Ltd - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME6331PD
  • |
  • Pages: 39
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.TB test that diagnoses both latent TB infection and active disease by measuring T cells that have been activated by Mycobacterium tuberculosis antigens. Oxford Immunotec's T-SPOT solution offers diagnosing disease by measuring immune response to an infection. The company offers laboratories services such as oxford diagnostics. It operates in the US, the UK, Japan, South Korea and China. Oxford Immunotec is headquartered in Abingdon, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Oxford Immunotec Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Oxford Immunotec Ltd Company Overview 5

Oxford Immunotec Ltd Company Snapshot 5

Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

Oxford Immunotec Ltd-Pipeline Analysis Overview 8

Oxford Immunotec Ltd-Key Facts 8

Oxford Immunotec Ltd-Major Products and Services 9

Oxford Immunotec Ltd Pipeline Products by Development Stage 10

Oxford Immunotec Ltd Pipeline Products Overview 12

Accutix-Tick-borne Disease 12

Accutix-Tick-borne Disease Product Overview 12

B Cell ELISPOT Assay 13

B Cell ELISPOT Assay Product Overview 13

ELISPOT Tumor Assay 14

ELISPOT Tumor Assay Product Overview 14

I-O Monitoring Test 15

I-O Monitoring Test Product Overview 15

Metabovis Assay-Homocysteine 16

Metabovis Assay-Homocysteine Product Overview 16

Nucleic Acid Amplification Test-Babesia 17

Nucleic Acid Amplification Test-Babesia Product Overview 17

Serology Test-Babesia 18

Serology Test-Babesia Product Overview 18

SpiroFind 19

SpiroFind Product Overview 19

Stratokine 20

Stratokine Product Overview 20

T-SPOT.CMV 21

T-SPOT.CMV Product Overview 21

T-SPOT.ICA 22

T-SPOT.ICA Product Overview 22

T-SPOT.PRT 23

T-SPOT.PRT Product Overview 23

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease 24

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease Product Overview 24

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease 25

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease Product Overview 25

Oxford Immunotec Ltd-Key Competitors 26

Oxford Immunotec Ltd-Key Employees 27

Oxford Immunotec Ltd-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 29

Oxford Immunotec Ltd, Recent Developments 29

Jun 05, 2018: Oxford Immunotec Applauds Updated Guidelines from the American Academy of Pediatrics Supporting Expanded Use of the T-SPOT.TB Test 29

Jun 04, 2018: Oxford Immunotec Announces Data Presentations for T-SPOT.CMV Test at the 2018 American Transplant Congress 29

May 22, 2018: Oxford Immunotec Announces Launch of the Accutix Brand 30

May 21, 2018: Oxford Immunotec's T-SPOT.TB Test Included in the World Health Organization's First-Ever Essential Diagnostics List 30

May 01, 2018: Oxford Immunotec Reports First Quarter 2018 Financial Results 30

Mar 06, 2018: FDA approves first tests to screen for tickborne parasite in whole blood and plasma to protect the U.S. blood supply 31

Mar 01, 2018: Oxford Immunotec Announces Appointment of Mark Klausner to the Board of Directors 32

Feb 27, 2018: Oxford Immunotec Reports Fourth Quarter and Full Year 2017 Financial Results 32

Jun 22, 2017: Oxford Immunotec Announces National Reimbursement for the T-SPOT.TB Test in France 34

May 02, 2017: Oxford Immunotec Reports First Quarter 2017 Financial Results 34

Appendix 36

Methodology 36

About GlobalData 39

Contact Us 39

Disclaimer 39

List of Figures

Oxford Immunotec Ltd Pipeline Products by Equipment Type 6

Oxford Immunotec Ltd Pipeline Products by Development Stage 10

List of Tables

Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

Oxford Immunotec Ltd Pipeline Products by Equipment Type 6

Oxford Immunotec Ltd Pipeline Products by Indication 7

Oxford Immunotec Ltd, Key Facts 8

Oxford Immunotec Ltd, Major Products and Services 9

Oxford Immunotec Ltd Number of Pipeline Products by Development Stage 10

Oxford Immunotec Ltd Pipeline Products Summary by Development Stage 11

Accutix-Tick-borne Disease-Product Status 12

Accutix-Tick-borne Disease-Product Description 12

B Cell ELISPOT Assay-Product Status 13

B Cell ELISPOT Assay-Product Description 13

ELISPOT Tumor Assay-Product Status 14

ELISPOT Tumor Assay-Product Description 14

I-O Monitoring Test-Product Status 15

I-O Monitoring Test-Product Description 15

Metabovis Assay-Homocysteine-Product Status 16

Metabovis Assay-Homocysteine-Product Description 16

Nucleic Acid Amplification Test-Babesia-Product Status 17

Nucleic Acid Amplification Test-Babesia-Product Description 17

Serology Test-Babesia-Product Status 18

Serology Test-Babesia-Product Description 18

SpiroFind-Product Status 19

SpiroFind-Product Description 19

Stratokine-Product Status 20

Stratokine-Product Description 20

T-SPOT.CMV-Product Status 21

T-SPOT.CMV-Product Description 21

T-SPOT.ICA-Product Status 22

T-SPOT.ICA-Product Description 22

T-SPOT.PRT-Product Status 23

T-SPOT.PRT-Product Description 23

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease-Product Status 24

UREA And T-SPOT Based Diagnostic Assay-Immunological Disease-Product Description 24

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease-Product Status 25

UREA And T-SPOT Based Diagnostic Assay-Infectious Disease-Product Description 25

Oxford Immunotec Ltd, Key Employees 27

Oxford Immunotec Ltd, Subsidiaries 28

Glossary 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

CME Medical UK Ltd

AorTech International Plc

Arcomedical Infusion Ltd

Oxford Immunotec Ltd, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 51878
Site License
USD 1500 INR 103755
Corporate User License
USD 2250 INR 155633

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com